StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck restructuring Costs ($M) ($M)

Postgres DB financial_values

QuarterlyAnnual
Latest, FY2025
889
Period ended Dec 31, 2025
Change on a year earlier
+187.7%
309 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring Costs ($M) ($M)Year on yearSource
FY2025Dec 31, 2025889+187.7%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 2024309-48.4%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 2023599+77.7%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 2022337-49.0%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 2021661+15.0%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 2020575-8.1%Form 10-K (filed 2022-02-25) ↗
FY2019Dec 31, 2019626-0.9%Form 10-K (filed 2022-02-25) ↗
FY2018Dec 31, 2018632-18.6%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 2017776+19.2%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 2016651+5.2%SEC Filing ↗
FY2015Dec 31, 2015619-38.9%Form 10-K (filed 2016-02-26) ↗
FY2014Dec 31, 20141,013-40.7%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20131,709+157.4%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 2012664-49.2%Form 10-K (filed 2013-02-28) ↗
FY2011Dec 31, 20111,306+32.6%Form 10-K (filed 2012-02-28) ↗
FY2010Dec 31, 2010985-39.7%Form 10-K (filed 2011-02-28) ↗

Cite this data

StockData. (2026). Merck Restructuring Costs ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_restr

See every metric in the Merck KPI table. Data updated Oct 26, 2026.